Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned

Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learnedActive surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned, Published online: 09 November 2018; doi:10.1038/s41571-018-0116-xBroad population screening of asymptomatic individuals for cancers of the prostate or thyroid has resulted in overdiagnosis and overtreatment. Herein, the authors describe the epidemiology, pathology, and screening guidelines for the management of patients with those cancers, and discuss existing international active surveillance protocols.

Source: Nature Clinical Practice Oncology - November 9, 2018 Category: Cancer & Oncology Authors: Lisa M. Lowenstein Spyridon P. Basourakos Michelle D. Williams Patricia Troncoso Justin R. Gregg Timothy C. Thompson Jeri Kim Source Type: research